| What's next for Biogen Idec http://www.boston.com/busin... Biotechnology Articles Boston Globe - Robert Coughlin, the new president of the Massachusetts Biotechnology Council, said drug makers are increasingly acquiring or taking stakes in biotech companies to help fill their product pipelines as patents on their old drugs expire. When that ... |
| Aker confident in outlook for key industries despite drop in Q3 ... http://www.forbes.com/afxne... Biotechnology Articles Forbes - A favourable outlook continues for Aker's most important industries: energy, maritime, seafood, and marine biotechnology,' it said. alastair.reed@thomson.com ar/ajb COPYRIGHT Copyright Thomson Financial News Limited 2007. All rights reserved. The copying ... |
| Altana, Bayer, Daimler, EADS, Munich Re: German Equity Preview http://www.bloomberg.com/ap... Biotechnology Articles Bloomberg - The biotechnology company may cut more than half of its 240 employees after a trial showed its experimental satraplatin cancer drug didn't help patients live longer, Euro am Sonntag said. The stock rose 9 cents, or 3 percent, to 3.10 euros ... |
| Biotech firms courting investors http://www.boston.com/busin... Biotechnology Articles Boston Globe - TransMolecular, based in Cambridge, is one of about three dozen local biotech companies slated to speak at the Massachusetts Biotechnology Council's annual investor conference in Boston Thursday, an opportunity for small to midsize growth companies ... |
| Teva to Acquire CoGenesys http://news.moneycentral.ms... Biotechnology Articles MSN MoneyCentral - Teva Pharmaceutical Industries Ltd. TEVA today announced that it has entered into a definitive agreement to acquire CoGenesys, Inc., a privately-held biopharmaceutical company with a broad based biotechnology platform and focused on the development ... |
| Rodman & Renshaw Capital Group, Inc. Announces Formation of London ... http://news.moneycentral.ms... Biotechnology Articles MSN MoneyCentral - Rodman is a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets. MEMBER ... |
| IDEX Corporation Acquires Isolation Technologies in a Strategic ... http://www.forbes.com/busin... Biotechnology Articles Forbes - The expansion of our Sapphire Engineering business will broaden our product offering, enhancing our ability to meet our customers' needs in the growing, global market for analytical, biotechnology and diagnostic instrumentation solutions." Rick ... |
| Earnings roundup: UTStarcom, Allstate http://www.cnbc.com/id/2135... Biotechnology Articles CNBC - SAN DIEGO (AP) -- Biotechnology company Amylin Pharmaceuticals Inc. said Wednesday its third-quarter loss narrowed on higher sales of its diabetes drugs Byetta and Symlin. MILWAUKEE (AP) -- Staffing firm Manpower Inc. said Wednesday its third-quarter ... |
| Research Alert: Top European Companies Lose Ground in Battle for Cash ... http://news.moneycentral.ms... Biotechnology Articles MSN MoneyCentral - Laggard sectors for CCE were Internet Software & Services (-75%), Biotechnology (-67%), and Leisure Equipment & Products (-38%). The REL/CFO Europe study finds two reasons to explain the decrease in cash as a percentage of sales. First ... |
| Get A Guide To Royalty Rates In Pharmaceutical Licensing Deals http://www.forbes.com/busin... Biotechnology Articles Forbes - Research and Markets (http://www.researchandmarkets.com/reports/c71991) has announced the addition of "A Guide to Royalty Rates in Pharmaceutical Licensing Deals" to their offering. The Importance of Royalties in Pharmaceutical and Biotechnology ... |